- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Policy Recommendations Arkansas
2020-21 Improvements and Recommendations
Drawing from a $1.3 million grant from the NIH, researchers at the University of Arkansas for Medical Sciences and the Arkansas Center for Health Improvement began a study on the overall health outcomes of medical cannabis use in the state. The study will examine product variety consumed by patients, motor vehicle accidents, opioid prescription rates, and the frequency of doctor’s visits, among other factors. Doctors in Arkansas will no longer be bound to a restricted conditions list; they will now be allowed to recommend medical cannabis for any patient they feel may benefit from it.
Arkansas patient enrollment has continued to grow at a steady pace adding just over 8,000 patients since our last report. Doctors in Arkansas will no longer be bound to a restricted conditions list; they will now be allowed to recommend medical cannabis for any patient they feel may benefit from it.
In 2022, ASA recommends legislators in Arkansas enact legislation that will protect the rights of minor cannabis patients to dose on school grounds, preferably with assistance from school staff like the nurse. The state should also look to expand retail access beyond the 38 dispensaries currently licensed as they are not likely to be enough to sufficiently meet patient demand and cover underserved areas. Arkansas officials should also consider allowing existing and future retailers to offer curbside pickup to patients as well as telemedicine for certifications and renewals. These measures were introduced across the country as measures to maintain safety during the COVID pandemic and measurably improved access. Many states chose to make these popular policies permanent; Arkansas should do the same. Finally, Arkansas lawmakers should consider allowing patients and caregivers to grow up to six plants at home.